Whether you are predicting the outcome of an election or studying how effective a new drug is, there will always be some uncertainty. A margin of error is how statisticians measure that uncertainty.
The number one scientific breakthrough for 2020: multiple vaccines to prevent COVID-19.
Philippe Raimbault/Photodisc via Getty Images
The development of multiple vaccines against the virus that causes COVID-19 has been hailed as the breakthrough of 2020. But there were many more supporting discoveries that made this possible.
Our AI made its predictions by looking at how cells changes and act under different conditions in the body.
elenabsl/ Shutterstock
Understanding how cells grow under a variety of conditions is necessary for diagnosing disease and developing treatments in the future.
A lab technician holds a vial of a COVID-19 vaccine candidate during testing at the Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand on May 25, 2020.
(AP Photo/Sakchai Lalit)
Will a vaccine for COVID-19 be safe? Animal testing, human clinical trials and post-approval surveillance give us good grounds to believe that a future approved vaccine will work and be safe.
Cardiovascular disease is the leading source of death worldwide.
PM Images / Getty Images
Scientists have developed and tested a new anti-clotting drug in mice that shows promise for treating heart attacks and stroke. It may also prove useful for COVID-19.
Are we really all in this together? ‘Vaccine nationalism’ must be addressed to ensure equitable distribution of a COVID-19 vaccine.
(Pixabay)
Word that the U.S. has bought up the entire supply of the COVID-19 drug remdesivir is another reminder that in a pandemic, treatments and vaccines need to be accessible to everyone, globally.
It usually takes 10 years for a new vaccine to complete clinical trials, but we've been promised a COVID-19 vaccine in 12 to 18 months. Even if such fast-tracked development is possible, is it wise?
Ayfer Ali, Warwick Business School, University of Warwick
Drug repurposing represents our only hope for the treatment of COVID-19 in the short term. But quick and rigorous trials need to be run to provide evidence these drugs work.
If the coronavirus is a lock, a drug to defeat it is a key that needs to fit just right.
Globally, billions of dollars in public funds have been committed for COVID-19 vaccine development. It’s crucial that the resulting vaccine be accessible to all.
(Shutterstock)
Canada is investing millions to develop COVID-19 treatments, but there are no safeguards to ensure that those vaccines and medications will be affordable and accessible to the people who need them.
It is critical to learn more about SARS-CoV-2, including its source and why transmission appears to be more efficient than with previous coronaviruses.
(Shutterstock)
The aim is to discover, develop and facilitate delivery of anti-malarial medicines to help tackle the burden of malaria in endemic countries and support malaria eradication.
A Brazilian soldier puts out fires.
AP Photo/Leo Correa
Destruction of rainforests through wildfires or deforestation may harm human health. As these forests disappear, we may be losing precious medicinal plants that hold treatments for various diseases.
Box jellyfish stings are excruciating and occasionally deadly. We have identified a common, cheap drug that is already on the market and which could be a treatment candidate with further development.
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney